2,396
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Identification of significant genes and therapeutic agents for breast cancer by integrated genomics

, , ORCID Icon, , , & show all
Pages 2140-2154 | Received 24 Mar 2021, Accepted 13 May 2021, Published online: 21 Jun 2021
 

ABSTRACT

Breast cancer is the most commonly diagnosed malignancy in women; thus, more cancer prevention research is urgently needed. The aim of this study was to predict potential therapeutic agents for breast cancer and determine their molecular mechanisms using integrated bioinformatics. Summary data from a large genome-wide association study of breast cancer was derived from the UK Biobank. The gene expression profile of breast cancer was from the Oncomine database. We performed a network-wide association study and gene set enrichment analysis to identify the significant genes in breast cancer. Then, we performed Gene Ontology analysis using the STRING database and conducted Kyoto Encyclopedia of Genes and Genomes pathway analysis using Cytoscape software. We verified our results using the Gene Expression Profile Interactive Analysis, PROgeneV2, and Human Protein Atlas databases. Connectivity map analysis was used to identify small-molecule compounds that are potential therapeutic agents for breast cancer. We identified 10 significant genes in breast cancer based on the gene expression profile and genome-wide association study. A total of 65 small-molecule compounds were found to be potential therapeutic agents for breast cancer.

Graphical Abstract

Acknowledgements

The authors acknowledge the National Natural Science Foundation of China 81972861, Innovation Capacity Support Plan of Shaanxi Province 2018TD‐002. We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript.

Availability of data and materials

All materials are available by the corresponding author.

Declarations

Ethical statement

Our study did not require an ethical board approval because it did not contain human or animal trials.

Consent for publication

Not applicable.

Disclosure Statement

The authors declare no competing interests.

Highlights

  1. Combined analyses of network-wide association studies, gene expression profiles, and drug databases.

  2. A useful approach for evaluating the relationship among genes, diseases, and drugs.

These findings will pave the way for the discovery of potential therapeutic targets for breast cancer.

Supplementary Material

Supplemental data for this article can be accessed here.

Additional information

Funding

This work was supported by the National Science Foundation of China [81972861]; The scientific development funding of the first affiliated hospital of Xi’an Jiaotong University (2020QN-07); The fundamental research funds for the central universities (xzy012020044).